Delta Virus Infection and Severe Hepatitis
An Epidemic in the Yucpa Indians of Venezuela
- STEPHEN C. HADLER, M.D.;
- MARIA DE MONZON, M.D.;
- ANTONIO PONZETTO, M.D.;
- ELIAS ANZOLA, M.D.;
- DALIA RIVERO, M.D.;
- ALEJANDRO MONDOLFI, M.D.;
- ANA BRACHO, M.D.;
- DONALD P. FRANCIS, M.D., D.Sc.;
- MICHAEL A. GERBER, M.D.;
- SWAN THUNG, M.D.;
- JOHN GERIN, Ph.D.;
- JAMES E. MAYNARD, M.D., Ph.D.;
- HANS POPPER, M.D., Ph.D.; and
- ROBERT H. PURCELL, M.D.
- Phoenix, Arizona; Maracaibo and Caracas, Venezuela; Rockville and Bethesda, Maryland; and New York, New York
Abstract
Over a 3-year period, 149 Yucpa Indians in Venezuela developed hepatitis; 34 persons died and at least 22 developed chronic hepatitis. Children and young adults were primarily affected, especially males. Serologic testing showed that hepatitis B virus infection was highly endemic in this population, but also that 65% of patients had hepatitis B virus surface antigen (HBsAg) during or after illness. Most patients had evidence of delta-agent superinfection; 86% of HBsAg-positive patients had delta antibody, and delta antigen was found in specimens taken during autopsies on 7 of 9 patients. Serologic data suggested that most infections were due to delta superinfection of hepatitis B carriers, and that more than 60% of these infections progressed to chronic disease. Delta agent infection, and particularly delta superinfection of hepatitis B carriers, appears to be an ominous occurrence that may develop in populations among whom hepatitis B virus infection is endemic, and who have no other risk factor for delta infection.
Article and Author Information
-
▸From the Division of Hepatitis and Viral Enteritis, CID, Centers for Disease Control, Phoenix, Arizona; South General Hospital, Maracaibo, Venezuela; the Ministry of Health, Caracas, Venezuela; Division of Molecular Virology, Georgetown University, Rockville, Maryland; the National Institutes of Health, Bethesda, Maryland; and Mt. Sinai School of Medicine, New York, New York.
-
▸Requests for reprints should be sent to Stephen C. Hadler, M.D.; Hepatitis Branch—Viral Diseases, Centers for Disease Control, 1600 Clifton Road, Building 6, Room 154; Atlanta, GA 30333.
RSS Feeds









